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Case presentation
An 8.5-month-old white male was admitted to the New Eng-
land Medical Center Hospital (NEMCH) for evaluation of heavy
breathing and vomiting. Following a normal gestation and deliv-
ery, the patient was discharged from a local hospital at 2 days of
age in apparent good health. During the first 6 hours at home, he
began to hyperventilate and was readmitted to the hospital. Se-
vere metabolic acidosis with an increased concentration of un-
measured anions was found; a tentative diagnosis of organic
acidosis was made, and the patient was transferred to NEMCI-1
for further evaluation.
At NEMCH, solvent chromatographic studies of the urine
revealed a prominent spot of methylmalonic acid (MMA), a find-
ing that was confirmed by gas chromotography and mass spec-
troscopy. Subsequently, enzyme assays on fibroblast cultures
from a skin biopsy were carried Out, which disclosed that the
child had a defect in the production of 5'-deoxyadenosylcobala-
mm: this defect appeared to be the only metabolic block. Thus, a
diagnosis of methylmalonic acidemia was made, and protein re-
striction and vitamin B12 therapy were begun.
On a regimen of I g of protein per kilogram of body weight per
day and vitamin B2 in an oral dosage of 5 mg, twice daily, his
growth and development proceeded normally, and the concen-
tration of MMA in the urine ranged from 2 to 7 mg/mg of creati-
nine. One month prior to admission, the dose of vitamin B12 was
reduced from 70 to 20 mglwk, hut because the concentration of
MMA in the urine increased to 17.8 mg/mg of creatinine, the
original dosage schedule was reinstituted 2 weeks prior to admis-
sion. Four days before admission, the patient became irritable
and began to eat less; 2 days before admission he began to vomit.
One day before admission, he was seen as an outpatient at
NEMCH for a scheduled routine visit. The laboratory findings
obtained during that visit and his subsequent admission are
shown in Table 1. The patient did not appear sufficiently ill to
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warrant hospitalization, and he was sent home. Over the next
several hours, however, vomiting continued, heavy breathing
developed, and he was admitted.
On admission, the physical examination revealed the following
data: temperature, 36.5° C: heart rate, 150/mm; respirations had
a Kussmaul quality at 50/mm; blood pressure, 90/50 mm Hg;
weight, 8.6 kg. The patient was responsive only to deep pain, but
there were no focal neurologic findings. The liver was palpable S
cm below the costal margin, but there were no other abnormal-
ities. Laboratory studies revealed the following data: hemoglo-
bin, 12.5 g/l00 ml; hematocrit, 38%; white blood cell count,
12,000/mm3. Results of urinalysis revealed: pH, 5; protein, 1+;
"heavy' ketones; no sediment abnormalities. Lumbar puncture
yielded clear spinal fluid that contained no cells. The patient was
treated with sodium bicarbonate, but 5 hours after admissiOn the
plasma bicarbonate concentration remained very low (see Table
1). On the first hospital day, peritoneal dialysis was instituted
using 200 ml of fluid per exchange, and 55 exchanges were ac-
complished. Seizures occurred and were treated with phenobar-
bital. Over the first 2 days, the patient's mental status improved
considerably.
The patient's hospital course was prolonged because of infec-
tion, skin breakdown, diarrhea, and poor nutrition. He was able
to tolerate as much as 0.9 g of protein per kilogram of body
weight per day, but was unable to tolerate 1.2 g of protein per
kilogram of body weight per day. At the latter level of protein
intake, the concentration of MMA in the urine was 10.5 mg/mg of
creatinine, and the plasma bicarbonate concentration was slight-
ly below normal. When the protein intake was reduced, the
plasma bicarbonate concentration stabilized at approximately 18
to 20 mEq/liter, and the urinary MMA concentration decreased
to 1.8 mg/mg of creatinine. During the hospitalization, it became
clear that neurological damage had occurred resulting in hypo-
tonia (especially manifested by very poor head control) and cho-
reoathetotic movements of the arms. At the time of discharge,
the overall developmental level was estimated to be 7 to 8
months at a chronological age of 1 year; neurologic function im-
proved somewhat in the 7 weeks after discharge.
Discussion
DR. J. J. COHEN (Professor of Medicine, TuJ'ts
University School of Medicine, Chief, Renal Ser-
vice, NEMCH): A variety of inborn errors of car-
bohydrate, amino acid, and possibly fatty acid me-
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tabolism lead to organic acidosis in neonates and
infants [11. The specific metabolic error and some of
the organic acids that accumulate have been identi-
fied in many of these entities, such as glycogen stor-
age disease (type I), maple syrup urine disease,
isovaleric acidemia (the "sweaty-feet" syndrome),
propionic acidemia, and methylmalonic acidemia.
These conditions, at one time designated as idio-
pathic acidosis of infancy, often result in life-threat-
ening acid-base disorders. The patient presented
today with methylmalonic acidemia provides us
with an opportunity to discuss not only this condi-
tion but also several principles concerning metabol-
ic acidosis, in general. Dr. Ampola, will you review
for us the clinical manifestations of methylmalonic
acidemia and the enzymatic defects responsible?
DR. MARY G. AMPOLA (Assoc. Professor of
Pediatrics, Tufts University School of Medicine
and Director, Pediatric Amino Acid Laboratory,
NEMCH) Methylmalonic acidemia is one of the in-
born errors capable of producing severe keto-
acidosis. It shares some clinical and biochemical
features with propionic acidemia because methyl-
malonyl coenzyme A (CoA) is just one step beyond
propionyl CoA on the way to the formation of succi-
nyl CoA (Fig. 1). Children with methylmalonic aci-
demia frequently develop their initial episode of
severe acidosis before 1 month of age.
Methylmalonic acid accumulation and excretion
is a critically important biochemical marker, but as
you will hear later from Dr. Cohen, this acid is not
quantitatively the most important organic acid re-
sponsible for the acidosis. Rather, accumulation of
I soleucine
Methionine ___________
Threonine
Valine
a variety of keto-acids is responsible. Clinically,
acidosis is often accompanied by vomiting, sei-
zures, hypoglycemia, hyperglycinemia, neutro-
penia, and thrombocytopenia. Hyperammonemia
may be profound and life threatening in itself. More
mildly affected patients manifest symptoms as late
as 18 months of age, but even in these patients life-
threatening episodes of ketoacidosis may occur.
Osteoporosis develops in about half of the patients.
Untreated children who survive are often small and
developmentally delayed, but some have normal in-
telligence.
The biochemistry of this interesting clinical dis-
order is illustrated in Figure 1. Four amino acids,
isoleucine, methionine, threonine, and valine, as
well as the odd-chain fatty acids and cholesterol,
lead to the formation of propionyl CoA. Normally,
propionyl CoA is converted to D-methylmalonyl
CoA, then to L-methylmalonyl CoA, and finally to
succinyl CoA. Methylmalonyl CoA mutase requires
a coenzyme, 5'-deoxyadenosylcobalamin (AdoCbl)
which is derived from vitamin B12 through a series
of enzymatic reactions. Vitamin B12 yields another
coenzyme, methylcobalamin (MeCbI), which is re-
quired for the conversion of homocysteine to me-
thionine.
At least five enzyme deficiencies may result in the
accumulation of MMA, each of which appears to be
inherited as an autosomal recessive [2, 3]. The sites
of each of these enzyme deficiencies is identified in
Figure 1. The first block, labeled D, is a defect in the
racemase apoenzyme and is represented by a single
case report. Another block, labeled J, is a defect in
Odd chain
Propionyl-C0A fatty acids
Cholesterol
U,
DMethylmalonyl-CoA
Fig. 1. Propionale and inethylmalonate metabolism showing the five defects that lead to methylmalonic acide,nia. AdoCbl denotes 5'-
deoxyadenosylcobalamin, MeChI denotes methylcobalamin, and MM-CoA denotes methylmalonyl coenzyme A. The defect in the
patient discussed here was at the site labeled®.
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Vitamin 812 ® MM-C0A
L-Methylmalonyl-C0A
A ® MM-C0A
AdoCbl Mutase
Succinyl-C0A
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the mutase apoenzyme. Three separate defects in
the formation of AdoCbl have also been described.
If the enzymatic defect involves only the formation
of AdoCbl, labeled and ®, then only MMA ac-
cumulates in body fluids. If, on the other hand, the
defect involves a reaction common to the formation
of both coenzymes (AdoCbl and MeCbl), then
homocystine and cystathionine as well as MMA ac-
cumulate. This latter defect is labeled in Figure
1. Often the defects in vitamin B12 metabolism are
not complete. The patient presented today was
shown by tissue culture techniques to hava a defect
in AdoCbl formation at the conversion labeled
The diagnosis of methylmalonic acidemia is often
suspected on clinical grounds, and it is readily con-
firmed by laboratory studies. Methylmalonic acid is
detectable in the urine by a relatively simple chem-
ical test or by paper chromatography with staining
by 0-dianisidine (Fast Blue B). Gas chromatogra-
phy confirms the identity of the MMA. This latter
test will also detect some accumulation of propionic
acid because the conversion of propionic to methyl-
malonic acids is reversible. The plasma concentra-
tion of vitamin B12 should be measured to rule out
B12 deficiency, which is known to cause modest ac-
cumulations of MMA in body fluids.
The precise enzyme deficiency can be confirmed
by an in vitro assay using cultured leukocytes or,
preferably, fibroblasts from an afflicted patient. Ad-
dition of AdoCbl to the tissue cultures from patients
with a coenzyme deficiency restores mutase activi-
ty, but does not do so if the mutase apoenzyme it-
self is lacking. In vitro responsiveness to vitamin
B12, however, is not reliable for predicing in vivo
effectiveness of vitamin therapy. It is possible to
make a prenatal diagnosis of methylmalonic acide-
mia from material obtained by amniocentesis 4].
Therapy for the acute episode consists of admin-
istering i.v. fluids and large quantities of bicarbo-
nate and glucose. Peritoneal dialysis, as in the pa-
tient under discussion, may be life saving. In an
acutely ill neonate whose responsiveness to vitamin
B12 has not been established, 1 mg/day of the vita-
min should be given parenterally since this therapy
is innocuous and may well lower MMA concentra-
tions rapidly.
Long-term therapy consists of administering a
diet of adequate caloric value containing 0.5 to 1.5 g
of protein per kilogram of body weight per day. This
regimen alone is satisfactory for most patients. Pa-
tients with AdoCbl deficiency often respond to vita-
min B12 given parenterally in a dosage of 1 mg/day
or orally in a dosage of 10 to 15 mg/day. Some pa-
tients with incomplete blocks require the B12 only
at weekly, monthly, or even trimonthly intervals,
since the coenzyme appears to be stored for long
periods. A few patients with coenzyme deficiency
have responded to administration of the coenzyme
itself, but there are major problems related to avail-
ability and stability of the preparations.
Patients with the mutase apoenzyme deficiency
are generally more difficult to manage than those
who are vitamin-responsive, but long-term therapy
with diets containing 0.5 to 1.0 g of protein per kilo-
gram of body weight per day has been successful in
many such patients. It is important to note, finally,
that a trial of vitamin 12 therapy should be given in
these patients as well, since the cells of one patient
with diminished affinity for its cofactor have been
reported to respond to AdoCbl in vitro.
DR. J. J. COHEN: Is there any theoretical reason
to suspect, or is there any empiric evidence to sug-
gest that patients with methylmalonic acidemia
would be seriously impaired were it not for the aci-
dosis? In other words, if these children could be
prevented from becoming acidotic, would there be
any other problems limiting their normal growth
and development?
DR. M. G. AMPOLA: I don't think so. Clinically,
children with methyimalonic acidemia behave in a
fashion similar to children with other organic acide-
mias. That is, their difficulties apparently are direct-
ly related to the degree of organic acidosis. If the
acidotic crises can be prevented, there seems to be
no developmental delay, and most of these children
grow normally even though blood concentrations of
MMA may be persistently elevated. The major goal
is to prevent the kinds of episodes that character-
ized the course of the patient presented today.
DR. J. J. COHEN: As we have just heard, were it
not for the life-threatening and indeed frequently fa-
tal metabolic acidosis that occurs in patients with
methyl malonic acidemia, this condition would
probably be of interest only as a biochemical curios-
ity. It is important, therefore, to understand fully
the pathogenesis of the acidosis in the hope that we
might develop strategies for preventing its occur-
rence. The simplest explanation, of course, is that
the acidosis in this condition stems directly from the
enzymatic impediment to the orderly removal of
MMA. One might imagine this substance accumu-
lating in large quantities when the pathway is
flooded with the four precursor amino acids, which
typically occurs following increased protein intake
or the breakdown of tissue proteins during infec-
tions or other intercurrent illnesses. This simplistic
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hypothesis must be rejected, however, because the
amount of MMA formed by children with this con-
dition is simply not sufficient to account for the se-
verity of the acidosis typically observed. Morrow et
al [5] described five patients with methylmalonic
acidemia and reviewed the findings of five pre-
viously reported cases. The highest value for
plasma MMA concentration in these patients was in
the range of 30 mg/l00 ml. The molecular weight of
this organic acid is 118 daltons (Fig. 2); thus, the
peak MMA concentration at the height of the acido-
sis was less than 3 mmoles/liter, whereas mean
plasma bicarbonate concentration is often reduced
by 20 mEq/Iiter or more. Moreover, the rate of uri-
nary MMA excretion during periods of decompen-
sation and intense acidosis was reported to be in the
range of 30 to 50 mmoles/day, a value quite similar
to that observed in the patient described here. For a
child with a body weight of approximately 10 kg,
this quantity corresponds to a production rate of
approximately 3 to 5 mmoles of MMA per kilogram
of body weight per day.
You may recall that children at this age have a
normal rate of endogenous acid production in the
range of some 2 to 3 mmoles/kg of body weight
per day. Thus, even at the maximum recorded rates
of MMA excretion, and presumably of MMA gener-
ation, the overproduction of this substance alone
does not increase the endogenous acid load by more
than a factor of 2 or 3. Such a doubling or tripling of
the endogenous acid load is far from sufficient to
produce the severe acidosis characteristic of this
condition. Therefore, as was recognized in the
earliest report of this condition [6], it is virtually
certain that MMA itself is not the only or even the
major source of the excess hydrogen ion that makes
these children so sick.
What other possibilities are there? The most
Methyirnalonic acid
(mol wt, 118.09 daltons)
CH3 CH (CO2 H)2
H
0
0
H C
H—C — C—H
H
0
0
H
Fig. 2. Chemical Structure of methylmalonic acid.
likely source appears to be one or more keto-acid.
Indeed, the acidosis of methylmalonic acidemia has
usually been categorized as a ketoacidosis because
of the consistent finding of a positive nitroprusside
reaction in both plasma and urine [6]. Methylmalonic
acid itself, of course, does not give a positive nitro-
prusside reaction because it has no ketone group.
The nature of the keto-acid or acids has not been
studied extensively. Rosenberg, Lilljeqvist and
Hsia [7] detected the long-chain ketones, butanone
and hexanone, in the urine of an infant with methyl-
malonic acidemia, but the quantity was not mea-
sured. Such long-chain ketones could derive from
odd-chain fatty acid precursors, which are known
to be metabolized through the propionic-methyl
malonic-succinic pathway (Fig. I).
Dr. Ampola, is this a tenable hypothesis from the
biochemical point of view? Are the reactions that
lead to propionyl CoA from the odd-chain fatty
acids reversible so that one could envision an accu-
mulation of keto-acids derived from that source if
there were a block beyond the level of propionic
acid? Alternatively, could MMA or some closely re-
lated compound result in some form of feedback or
exert some toxic effect that might retard the metab-
olism of these acids and permit them to accumu-
late?
DR. M. G. AMPOLA: The formation of propionyl
CoA is not reversible, but, as you suggest, there
could be other effects that might lead to an increase
in keto-acid formation.
DR. J. J. COHEN: In any event, because a positive
nitroprusside reaction is a universal finding in pa-
tients with methylmalonic acidemia, it seems quite
likely that one or more keto-acid is playing a major
role. Unfortunately, as far as I know, no quan-
titative assessment of keto-acids concentrations has
been made in this condition. It is also conceivable
that lactic acid makes some contribution. Although
lactate concentrations are said to be elevated" in
some of these children, the extent of the elevation
has not, to my knowledge, been reported. Lactate
concentration was not measured in the patient we
are describing today.
DR. WILLIAM B. SCHWARTZ (NEMCH): Since
the main problem is the acidosis, it is curious that a
major effort hasn't been made to identify the acids.
Is the technical problem of identifying them so ex-
tremely difficult?
DR. M. G. AMPOLA: They are not particularly dif-
ficult to identify using the gas chromotographic
techniques now available. In fact, this patient has
stimulated our interest in collecting such data.
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DR. J. J. COHEN: The published reports pay very
little attention to this issue. Instead, concern has
centered on development of diagnostic techniques
for rapid identification of methylmalonic acidemia
and on the identification of the specific enzymatic
defect.
DR. W. B. SCHWARTZ: If the precise nature of the
relevant acids were known, might it not then be
possible to develop some useful strategies for pre-
vention of the acidosis.
DR. M. G. AMPOLA: I don't know of any diets
that prevent the accumulation of fatty acids. Fur-
thermore, should it become clear that lactic acid is
important, it doesn't seem likely that alteration of
the diet would be a viable therapy in methylmalonic
acidemia. In order to prevent accumulation of lactic
acid in other circumstances, such as glycogen stor-
age disease (type I), it is necessary to administer a
low-carbohydrate, high-protein diet. This is pre-
cisely what we can't do in patients with methyl-
malonic acidemia.
DR. J. J. COHEN: Clearly, we wouldn't be any
worse off than we are now in approaching the prob-
lems of prevention and therapy if the acids were
well defined.
DR. J. T. HARRINGTON: Although we don't have
a measurement of plasma MMA concentration in
the patient presented today, is it possible to esti-
mate what it might have been on the basis of infor-
mation in the literature and the quantitative urinary
MMA excretion?
DR. J. J. COHEN: If one uses a reasonable figure
for daily creatinine production, one can estimate
from the random urine value of 42 mg of MMA per
milligram of creatinine that the patient was ex-
creting approximately 48 mmoles of MMA/24 hr.
This value is almost identical to the highest urinary
MMA values reported by Morrow et al [51; the pa-
tient they describe with this level had a simultane-
ous plasma MMA value of 36 mg/l00 ml, that is,
about 3 mmoles/liter.
RENAL FELLOW: Knowing that insulin prevents
the accumulation of keto-acids, has anybody tried
to administer insulin or raise endogenous insulin
concentrations by administering a high-carbohy-
drate diet? Might that regimen prevent the accumu-
lation of keto-acids?
DR. M. G. AMPOLA: To my knowledge, no one
has tried administering insulin to patients with
methylmalonic acidemia. We routinely treat them
with a very high carbohydrate diet, however. We
use polycose to avoid the problems of diarrhea and
aim for 130 to 140 calories per kilogram of body
weight per day. Our reason for using a high-car-
bohydrate diet, however, is to spare protein.
DR. J. P. KASSIRER: Has anyone measured
plasma insulin or looked at insulin receptors in
these patients?
DR. M. G. AMPOLA: Not to my knowledge.
DR. J. J. COHEN: As Dr. Ampola mentioned ear-
lier, hypoglycemia is frequently present during epi-
sodes of acidosis in patients with methylmalonic
acidemia. So there is a suggestion that something
may be wrong with the metabolism of glucose.
DR. JOHN T. HERRIN (Chief, Pediatric Nephrol-
ogy, Massachusetts General Hospital): Hypogly-
cemia is undoubtedly present, but glucose utiliza-
tion is not that markedly increased. These patients
usually respond to very small amounts of glucose,
and the increased glucose concentration is sustained
without the need for much supplementation. We
often administer higher doses of sugar during an
acidotic episode to supply adequate calories in the
absence of fat and protein intake.
DR. J. J. COHEN: There is no reason to believe, I
gather, that a low-protein diet is beneficial only be-
cause of the resulting high-carbohydrate content.
DR. M. G. AMPOLA: Definitely not. If the poly-
cose and corn oil intake remains constant, MMA
concentration can be shown to vary directly with
the protein intake.
DR. J. J. COHEN: It is clear that a good deal more
work needs to be done to clarify the pathogenesis of
the acidosis in this condition. Regardless of what
acid or acids prove to be involved, however,
methylmalonic acidemia provides an instructive ex-
ample of those forms of metabolic acidosis pro-
duced by an overproduction of endogenous acid.
The more common varieties of this class of meta-
bolic acidoses include diabetic ketoacidosis, lactic
acidosis, the B-hydroxy butyric acidosis occasion-
ally seen in alcoholics, and the acidosis produced
by several poisons (e.g., methanol, ethylene glycol,
paraldehyde, salicylate). In each of these circum-
stances, the tipoff that the acidosis is a consequence
of an overproduction of endogenous acid is the find-
ing of an increased unmeasured anion concentration
or "anion gap." If one defines the anion gap as the
difference between serum sodium concentration
and the sum of serum chloride and bicarbonate con-
centrations, the normal values range between 8 and
12 mEq/liter. When the rate of endogenous acid
production outstrips the kidneys' ability to increase
net acid excretion, the resulting decrement in
plasma bicarbonate concentration is associated
with a virtually equivalent increment in the concen-
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tration of unmeasured anions. This increment in un-
measured anion concentration is caused, of course,
by an accumulation of the anion of the acid in ques-
tion. Indeed, there is usually a good correlation be-
tween the decrement in plasma bicarbonate concen-
tration and the increment in unmeasured anion con-
centration in patients with untreated, organic
acidosis. This is well illustrated in the patient under
discussion today in whom the admission laboratory
findings revealed a plasma bicarbonate concentra-
tion of 3 mEq/liter—some 20 to 25 mEq/liter below
normal—and an unmeasured anion concentration of
37 mEq/liter—some 25 mEq/liter above normal (see
Table 1).
There are circumstances, however, in which the
increment in the anion gap is found to be notably
greater than the apparent decrement in plasma bi-
carbonate concentration. Such a finding should
raise the possibility of a coexisting, hidden" meta-
bolic alkalosis; if one imagines a patient with an ele-
vated plasma bicarbonate concentration prior to the
onset of metabolic acidosis, it is easy to envision
how the subsequent titration of bicarbonate to a
frankly low value would be accompanied by what
would appear to be an excessive increment in the
concentration of unmeasured anions. Such a hidden
metabolic alkalosis, in the company of "anion gap"
acidosis, is not uncommon in patients who have a
history of vomiting prior to or during the develop-
ment of the organic acidosis. It is also a frequent
feature, as illustrated in the patient being discussed
today, of the early treatment phase of severe organ-
ic acidosis. The administration of large quantities of
sodium bicarbonate, as is often required in treating
these forms of metabolic acidosis, may be followed
by only a trivial increment in plasma bicarbonate
concentration but by a continued widening of the
anion gap. The explanation for this alteration is that
a large fraction, if not most of the administered bi-
carbonate, is immediately utilized in the buffering of
newly formed endogenous acid. In our patient
whose body weight was 8.6 kg, 60 mEq of sodium
bicarbonate were administered, but this therapy re-
sulted in at most a 1 mEq/liter increment in plasma
bicarbonate concentration and the unmeasured ani-
on concentration increased further to a value great-
er than 50 mEq!liter (see Table 1). Since the space
of distribution of bicarbonate is approximately 50%
of body weight, the administration of 60 mEq of al-
kali to such a small child would have increased
plasma bicarbonate concentration by some 14 mEq/
liter were it not for continued acid production (or
bicarbonate loss). Said another way, the failure of
60 mEq of sodium bicarbonate to produce any in-
crement in plasma bicarbonate concentration al-
lows one to estimate that approximately 60 mmoles
of newly formed acid were released into the body
fluids over that brief interval.
Given this truly striking rate of endogenous acid
production, how much bicarbonate should have
been given to treat the resulting severe metabolic
acidosis? The answer to that question is easy: Just
Table 1. Clinical laboratory values found during an acidotic crisis in an 8-month-old child with methylmalonic acidemia
Times at which values were recorded
A — I daya A A + 5 hr A + 2 days A + 3 days A + 12 days
Serum
Sodium,inEq/liter 144 140 157 144 140 139
Potassium, mEqiliter 3.7 4.0 3.3 4.5 4.2 4.9
Chloride, inEqilirer 107 100 100 106 109 104
Bicarbonate, mEqI/irer 20 3 4 23 21 23
Unmeasured anions, ,nEqlliterb 17 37 53 15 10 12
Creatinine,mg/lOOml — 1.8 0.6 0.3 0.3
Urea nitrogen, mg/100 in! — 32 .— 6 3 5
Glucose, mg/tOO ml — 72 -.— 103 — 95
pH — 7.06 7.18 7.53 7.49 7.42
Blood gases
Carbon dioxide tension, mm Jig
Urine
— 11 11 28
1'
28 37
Methylmalonic acid, mg/ing of creatinme 15 42
Ketones heavy"
Treatment sodium peritoneal
bicarbonate dialysis
(60 mEq)
A denotes time of admission to NEMCH.
Calculated as [sodium — (chloride + bicarbonate)].
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enough, but not too much. Unfortunately, there is
no way of anticipating beforehand how much alkali
will be required in patients with organic acidosis to
insure a successful outcome. At one extreme are
patients in whom the increase in organic acid pro-
duction is so short lived and so promptly followed
by the complete metabolism of the organic acid,
that no exogenous alkali is required. A nice ex-
ample of this is the transient lactic acidosis that of-
ten accompanies generalized convulsions [8]. At the
other extreme are patients, such as the OflC we are
discussing, in whom the rate of acid production is
truly enormous and unrelenting. Under these latter
circumstances, there is no alternative to the empiric
approach. As with this patient, acid-base parame-
ters must be monitored frequently in order to assess
the efficacy of therapy and to provide guidance for
further management.
Frequently, the quantity of sodium bicarbonate
required to treat the acidosis provides a sodium
load in excess of the amount the kidneys can ac-
commodate. This is especially true when kidney
function is impaired, which it so often is in these
seriously ill patients. Again, our patient illustrates
this principle well. A serum creatinine concentra-
tion of 1.8 mg/lOO ml in a child this age is consistent
with at least a 75% reduction in GFR. It is frequently
necessary, therefore, to administer diuretics or to
employ peritoneal dialysis or hemodialysis to has-
ten the removal of the unneeded sodium. Peritoneal
dialysis was employed in this patient with good re-
sults and served not only to maintain normal fluid
balance but also to provide a continued source for
the needed alkali. A related and also unwanted con-
sequence of the rapid administration of sodium bi-
carbonate is the appearance of hypernatremia,
again exemplified in this patient. Hypernatremia oc-
curs, of course, because of the hypertonic nature of
the sodium bicarbonate solutions administered and
may be another factor in the decision to employ
dialysis.
The typical clinical manifestations of severe
metabolic acidosis are also well illustrated by the
patient under discussion and include stupor, vomit-
ing, and deep rapid respirations. The hyper-
ventilation triggered by metabolic acidosis deserves
special comment. There has been considerable un-
certainty about the precise mechanisms responsible
for stimulating ventilation during metabolic acido-
sis. One school of thought, championed by Mitchell
et al [91 and others, contends that peripheral chem-
oreceptors are stimulated by the acidemia and pro-
vide the afferent arc for this reflex mechanism. The
work of Fend, Miller and Pappenheimer [10], on
the other hand, has provided what I believe to be
convincing evidence that the control of ventilation
during metabolic acid-base disturbances is mediat-
ed by the hydrogen ion concentration within the ce-
rebral interstitial fluid bathing the respiratory cen-
ters in the brain stem. These workers conducted an
elegant and exhaustive series of experiments using
unanesthetized goats fitted with permanent ven-
tricular cannulae that allowed repeated sampling of
intraventricular cerebral spinal fluid. They were
able to show that very small but definite changes in
cerebral spinal fluid pH occurred following the in-
duction of metabolic acidosis and that these small
changes were sufficient to account for the degree of
hyperventilation observed. They hypothesized that
the blood-brain barrier reduced the decrement in
cerebral interstitial fluid bicarbonate concentration
that would otherwise occur following a fall in
plasma bicarbonate concentration, thereby limiting
the change in cerebral hydrogen ion concentration
to about one-fourth to one-fifth of that which occurs
in blood. Nevertheless, owing to the exquisite sen-
sitivity of the cerebral respiratory centers to the lev-
el of local acidity, which was also nicely demon-
strated in their experiments, the pronounced
changes in alveolar ventilation could easily be ac-
counted for.
The presence of a blood-brain barrier that modi-
fies the magnitude of the bicarbonate decrement in
cerebral interstitial fluid would also account for the
well-known delay in the onset and offset of full res-
piratory adaptation to metabolic acidosis. It ap-
pears that at least a few hours is required in order
for final steady-state adjustments in ventilation to
occur in response to a given stable reduction in
plasma bicarbonate concentration [11, 12]. The
steady-state relationships between the degree of
secondary hyperventilation and the magnitude of
the initiating metabolic acidosis has been examined
by several workers and constitutes, if you will, the
outward manifestation of the ventilatory control ex-
erted by cerebral acid-base equilibrium.
The various studies that have examined the quan-
titative relationship between the decrement in arte-
rial carbon dioxide tension (Paco2) and the initiating
decrement in plasma bicarbonate concentration
have yielded surprisingly similar results [13—17]. On
the average, during steady-state periods of metabol-
ic acidosis, it appears that each mEq/liter reduction
in plasma bicarbonate concentration is associated
with approximately 1.1 to 1.3 mm Hg reduction in
Paco2. I think it is of considerable interest that this
relationship, when extrapolated to the lowest
ranges of plasma bicarbonate concentration (such
as those encountered in our patient), predicts a de-
gree of secondary hypocapnia that is just at the
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lower limit of what is achievable physiologically.
Recall that voluntary hyperventilation can decrease
Paco2 only so long as the increased work of breath-
ing does not augment carbon dioxide (co2) produc-
tion to such a degree that the increased rate of co2
excretion cannot keep pace. Individuals with nor-
mal ventilatory mechanics can achieve a minimum
Paco2 of approximately 10 mm Hg, that is, a dec-
rement of some 30 mm Hg below normal. Based on
the empiric relationships observed in patients with
stable metabolic acidosis, such an extreme decre-
ment in PaCo2 would be anticipated only in associa-
tion with vanishingly low plasma bicarbonate con-
centrations. In the patient under discussion today,
plasma bicarbonate concentrations in the 2 to 3
mEq/liter range were associated with the remark-
ably low Paco2 values of 10 to 11 mm Hg.
It is always advisable to assess the degree of sec-
ondary hyperventilation in any patient with meta-
bolic acidosis in an effort to assess whether coexist-
ing respiratory abnormalities might be present. If
the degree of secondary hypocapnia falls short of
the anticipated level, some factor impeding ventila-
tion may be present. Conversely, if the degree of
hyperventilation is in excess of that attributable
solely to a given degree of metabolic acidosis, an
independent stimulus to ventilation should be
sought. It is important to bear in mind that these
comments refer only to circumstances in which
acid-base equilibrium has had a chance to stabilize.
In interpreting the relationship between PaCo2 and
plasma bicarbonate concentration in patients with
metabolic acidosis, one must be cognizant of the lag
in the ventilatory response. If one is dealing with a
patient in whom metabolic acidosis has just ap-
peared, the ventilatory response might well be less
extensive than that observed a few minutes or hours
later, even if the bicarbonate concentration remains
stable. Conversely, in patients in whom metabolic
acidosis is undergoing rapid correction, hyper-
ventilation typically lingers for some time after the
plasma bicarbonate concentration has been partial-
ly or completely restored to normal. Indeed, if one
follows a patient closely during the treatment of se-
vere metabolic acidosis, one can frequently detect a
period in which persistent hyperventilation in the
face of an improving concentration of plasma bi-
carbonate produces a frankly alkaline blood pH.
Again, this phenomenon is illustrated nicely by the
patient under discussion: Normalization of plasma
bicarbonate was associated with a transient alka-
lemia (blood pH, 7.53) due to persistent hyper-
ventilation (see Table I).
DR. J. T. HERRIN: Blood ammonia concentra-
tions are often strikingly elevated in children with
acidemias. Do you think hyperammonemia might
have contributed to the patient's hyperventilation?
DR. J. J. COHEN: Hyperventilation due to ele-
vated concentrations of ammonia has been postulat-
ed as a mechanism for the primary respiratory alka-
losis frequently observed in patients with cirrhosis
[181. There is also experimental evidence in animals
that hyperammonemia stimulates ventilation [19-
211. In the patient discussed today, however, we are
not forced to postulate that there was an independ-
ent stimulus to ventilation beyond that provided by
the metabolic acidosis itself. Admittedly, this con-
tention rests on the assumption that the empiric
Paco2-bicarbonate relationship characteristic of
moderately severe metabolic acidosis can be ex-
trapolated to situations in which plasma bicarbo-
nate is reduced to these very low concentrations.
This is not to say that the high ammonia concentra-
tion might not have played a role in accelerating the
appearance of hyperventilation or in delaying its
disappearance.
DR. J. T. HERRIN: I have been impressed that the
ammonia concentrations in patients such as this are
often much higher than those that have been found
in patients with liver failure. It is not uncommon,
for example, for a patient with methylmalonic aci-
demia or propionic acidemia to have ammonia con-
centrations of 800 to 2,000 tg/ml. These are astro-
nomic concentrations and may contribute in some
way to the clinical picture.
DR. M. G. AMPOLA: We followed a patient last
year with ornithine transcarbamylase (OTC) defi-
ciency, which is a defect at step 2 of the urea cycle.
Between 7 and 8 months of age, this child had a
very difficult time with hyperammonemia. We
noted that he hyperventilated whenever the plasma
ammonia concentration reached 450 to 500 gIml,
but that his respirations were normal when the
plasma ammonia concentration was less than 200
pgIml.
DR. J. J. COHEN: That is interesting. I gather this
occurred in the absence of acidosis?
DR. M. G. AMPOLA: That's right, the child was
not acidotic. Campbell et al [221 published data
from two cases of OTC deficiency. Both patients
died shortly after birth following an interval of pri-
mary hyperventilation associated with very high
blood ammonia concentrations.
DR. J. T. HERRIN: We described a similar finding
in a patient with OTC deficiency some years ago
[231.
DR. J. P. KASSIRER: When this patient was seen
in the clinic one day before admission to the hospi-
tal, he had a plasma bicarbonate concentration of 20
mEq/liter and an anion gap of 17 mEq/liter. The
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next day he was admitted to the hospital with a
plasma bicarbonate concentration of 3 mEq/liter
and an anion gap of 37 mEq/liter. I have two ques-
tions. First, what triggered the enormous and sud-
den increase in the production or decrease in utili-
zation of organic acid during that 24-hr period? Sec-
ond, is this a frequent occurrence among patients
with methylmalonic acidemia?
DR. J. J. COHEN: It is, in fact, quite typical for
patients with methylmalonic acidemia to develop
severe acidosis within a few hours. Sometimes it is
possible to identify a precipitating cause such as an
intercurrent catabolic illness or an increase in the
dietary intake of protein. I interpret this to mean
that both catabolic processes and exogenous pro-
tein can increase the flow of metabolites into the
blocked pathway, resulting either in a simple piling
up of acidic precursors or in some form of stimulus
to the overproduction of organic acids derived from
other pathways. As a consequence, the resulting
acidosis is greatly amplified. It is certainly not un-
precedented for the overproduction of endogenous
acid to result in a rapid appearance of severe meta-
bolic acidosis. This is commonly seen, for example,
in lactic acidosis and diabetic ketoacidosis.
DR. J. P. KASSIRER: I wonder about that inter-
pretation. Although we can measure MMA and we
find it elevated, there are many other organic acids
produced that we are not able to measure. How do
we know, therefore, that the excess of MMA is rep-
resentative of the primary disturbance? Is it pos-
sible that it is simply a marker? in other words,
could there be two jointly inherited enzymatic de-
fects, one responsible for the bulk of the acidosis,
and the other responsible for the detectable but
quantitatively less important elevation in MMA?
DR. J. J. COHEN: The severity of the acidosis
does seem to be reasonably well correlated with the
concentrations of methylmalonate. Moreover, dur-
ing periods in which acid-base equilibrium is nor-
mal, there is an abnormal quantity of methyl-
malonate in the urine but the excretion rate is much
lower than during acute episodes. These observa-
tions, however, do not exclude the possibility of
two independent defects.
DR. M. G. AMPOLA: I think the possibility of two
defects is unlikely. Using the fibroblast culture sys-
tem, one can assay a whole series of enzymes and
demonstrate that they all function normally except
the one in question. This is true not only of methyl-
malonic aciduria but also of isovaleric acidemia and
maple syrup urine disease. These assays are reliable
and specific.
DR. J. T. HARRINGTON: if one is faced with a se-
verely acidotic 2 or 3-day-old child, what types of
organic acidemia should immediately come to
mind?
DR. M. G. AMPOLA: Isovaleric, propionic, and
methylmalonic acidernia are the most common.
DR. J. J. COHEN: Do you know whether we face
the same problem in those other conditions; is there
a similar discrepancy between the amount of acid
that is specifically blocked and the degree of the
acidosi s?
DR. J. T. HERRIN: Our experience with propionic
acidemia is similar. There is an enormous require-
ment for bicarbonate despite dialysis, and the blood
concentration of propionic acid is not nearly high
enough to explain the acidosis.
DR. JOSEPH MARTENO (St. Elizabeth's Hospital,
Brighton, Massachusetts): Does peritoneal dialysis
remove the MMA?
DR. J. T. HERRIN: Yes, I believe it does. It also
removes branched-chain amino acids.
DR. J. MARTINO: Does the removal of MMA have
anything to do with improving the metabolic acido-
sis?
DR. J. J. COHEN: Unless the methylmalonate
were playing a toxic role, removal of the organic
acid anion from the circulation would not, in and of
itself, correct the metabolic acidosis. Replacing the
methylmalonate and whatever other organic anions
might be present with alkali or an alkali precursor
such as lactate or acetate would serve to repair the
acid-base disturbance nonspecifically.
DR. M. G. AMPOLA: It has been well shown in all
of the organic acidemias that, for the most part,
peritoneal dialysis works very nicely; in fact, it
works better than exchange transfusion.
DR. J. J. COHEN: I don't think that is too surpris-
ing in view of the large source of potential alkali that
peritoneal dialysis provides.
DR. J. T. HERRIN: Actually, peritoneal dialysis
works better than hemodialysis. There are several
reasons for this. Thefirst relates to problems of vas-
cular access in small infants. The second relates to
the inability of infants to tolerate large volume
changes. The volume tolerance of an 8-mo-old is
about 35 ml; in other words, to avoid hypovolemia
and the possibility of superimposed lactic acidosis,
on the one hand, or volume overload on the other
hand, it is necessary to maintain a fluid balance of
35 ml. This just isn't very practical with hemo-
dialysis. Third, if you consider the ratio of perito-
neal surface to body surface area, it is relatively
large when the body is small; so much so that the
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relative efficiency of peritoneal dialysis versus he-
modialysis at age 2 is about 1 to 2. This means that
peritoneal dialysis is fully half as efficient as hemo-
dialysis [24]. That is, you can accomplish as much
with 12 hours of peritoneal dialysis as you can with
6 hours of hemodialysis. In view of its greater
safety, this makes peritoneal dialysis preferable. In
adults, by contrast, peritoneal dialysis is only ap-
proximately one-fifth as efficient as hemodialysis.
Finally, peritoneal dialysis is very efficient in re-
moving large sodium loads; this allows one to infuse
as much sodium bicarbonate as needed to correct
the acid-base disturbance without producing intol-
erable sodium surfeits. The efficiency of peritoneal
dialysis is not an unmixed blessing, however. It also
creates a problem for us because of the removal of
normal amino acids from the circulation. Fortunate-
ly, we can replace these losses by administering
synthetic amino acid mixtures. We gauge the rate of
replacement by measuring blood amino acid con-
centrations three or four times a day and adjusting
the infusion rate accordingly.
Reprint requests to Dr. Jordan J. Cohen, Renal Service, New
England Medical Center Hospital, 171 Harrison Avenue, Bos-
ron, Massachusetts 02111
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The editors should like to expand the scope of these exercises by encouraging active partici-
pation of the journal's readership in Nephrology Forum. Questions or comments pertaining to
this month's discussion may be submitted toNephrology Forum, Box 212, New England Medi-
cal Center Hospital, 171 Harrison Avenue, Boston, Massachusetts 02111. To be eligible for
publication correspondence must be received by April 30, 1979.
